Abstract
Ninety-one patients with recurrent or metastatic colorectal adenocarcinoma were studied according to the anatomic areas of the recurrent tumor. In Group A, 30 patients with anastomotic recurrence, diagnosis was made in the majority within two years from initial surgery; most of them had specific symptomatology. A significant number of patients had blood in the stools. In half of the patients, complete resection of the recurrent tumor was feasible. In Group B, 47 patients with intra-abdominal recurrence, there was some delay in diagnosis; the symptomatology was less specific, and fewer patients were rendered free of tumor following reresection. The median survival and estimated five-year survival rate were, in both groups, strongly related to the completeness of the resection. In Group C, with distant metastasis (eight patients with pulmonary and six with liver metastasis), the disease-free interval was longer compared to the previous groups. The metastatic tumor was found in three patients, four or more years after the initial surgery. The median survival was the same as in the two other subgroups with complete resection of the recurrent tumor.
Similar content being viewed by others
References
American Cancer Society. Cancer: facts and figures, 1979.
Welch JP, Donaldson GA. Recent experience in the management of cancer of the colon and rectum. Am J surg 1974;85:258–66.
Silverman DT, Murray JL, Smart CR, Brown CC, Myers MH. Estimated median survival times of patients with colorectal cancer based on experience with 9,745 patients. Am J Surg 1977;133:289–97.
Gunderson LL, Sosin H. Areas of failure found at reoperation (second or symptomatic look) following “curative surgery” for adenocarcinoma of the rectum: clinicopathologic correlation and implications for adjuvant therapy. Cancer 1974;34:1278–92.
Floyd CE, Corley RG, Cohn I {jrJr.} Local recurrence of carcinoma of the colon and rectum. Am J Surg 1965;109:153–9.
Wilson SM, Beahrs OH. The curative treatment of carcinoma of the sigmoid, rectosigmoid, and rectum. Ann. Surg 1976;183:556–65.
Welch JP, Donaldson GA. Detection and treatment of recurrent cancer of the colon and rectum. Am J Surg 1978;135:505–11.
Winchester DP, McBride CM. Cancer of the colon: a comparison of survival factors. South Med J 1974;67:1025–30.
Moertel CG. Large bowel. In: Frei E {jrIII}, Holland JF, eds. Cancer medicine. Philadelphia: Lea & Febiger, 1973.
Cedermark BJ, Blumenson LF, Pickren JW, Holyoke DE, Elias EG. The significance of metastases to the adrenal glands in adenocarcinoma of the colon and rectum. Surg Gynecol Obstet 1977;144:537–46.
Welch JP, Donaldson GA. The clinical correlation of an autopsy study of recurrent colorectal cancer. Ann Surg 1979;189:496–502.
Polk HC {jrJr}, Spratt JS {jrJr.} Recurrent colorectal carcinoma: detection, treatment, and other considerations. Surgery 1971;69:9–23.
Bacon HE, Berkley JL. The rationale of re-resection for recurrent cancer of the colon and rectum. Dis Colon Rectum 1959;2:549–54.
Moertel CG, Schutt AJ, Go VL. Carcinoembryonic antigen test for recurrent colorectal carcinoma: inadequacy for early detection. JAMA 1978;239:1065–6.
Martin EW {jrJr.} Cooperman M, King G, Rinker L, Carey LC, Minton JP. A retrospective and prospective study of serial CEA determination in the early detection of recurrent colon cancer. Am J Surg 1979;137:167–9.
Author information
Authors and Affiliations
About this article
Cite this article
Vassilopoulos, P.P., Ledesma, E.J., Yoon, J.M. et al. Surgical treatment of metastatic colorectal adenocarcinoma. Dis Colon Rectum 24, 265–271 (1981). https://doi.org/10.1007/BF02641874
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02641874